iShares突破性环境解决方案ETF ETEC 深 沪
等待开盘 07-02 09:30:00 美东时间
30.2244
-0.333
-1.09%
华盛通- 最 高30.70
- 今 开30.70
- 成交量 821股
- 最 低 30.2244
- 昨 收 30.5576
- 总市值 483.59万
- 52周最高 32.3041
- 市盈率 静 --
- 换手率 0.51%
- 52周最低 20.4981
- 委 比 0.00%
- 总股本 16.00万
- 历史最高 32.3041
- 量 比 0.73
- 振 幅 1.56%
- 历史最低 15.5384
- 每 手 1
- 风险率 2.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SciBase, Castle Biosciences enroll first patient in DETECT-AD study testing EIS to predict atopic dermatitis flares
SciBase, Castle Biosciences enroll first patient in DETECT-AD study testing EIS to predict atopic dermatitis flares SciBase enrolled the first patient in DETECT-AD, a multicenter prospective study with Castle Biosciences in atopic dermatitis. Electrical Impedance Spectroscopy will be evaluated for i
06-10 14:46
BRIEF-Bioretec Ltd - Manager's Transactions - Jordy Winters
BRIEF-Bioretec Ltd - Manager's Transactions - Jordy Winters June 2 (Reuters) - Bioretec Oy BRETEC.HE : BIORETEC LTD - MANAGER'S TRANSACTIONS - JORDY WINTERS Source text: ID:nPrewXSr9a Further company coverage: BRETEC.HE (((( Reuters.Briefs@thomsonreuters.com ;));))
06-02 18:55
Epiminder Hits Key Enrolment Milestone in U.S. Epilepsy Study
Epiminder Ltd. ( ($AU:EPI) ) has shared an announcement. Epiminder has reached ...
06-01 07:18
VolitionRx posts corporate deck outlining Nu.Q diagnostics licensing strategy for cancer, sepsis and veterinary markets
VolitionRx posts corporate deck outlining Nu.Q diagnostics licensing strategy for cancer, sepsis and veterinary markets VolitionRx highlighted an asset-light strategy focused on licensing diagnostics IP, targeting multiple human-health licensing deals in 2026. Veterinary business showed $23 million
05-28 18:59
Transcript: Valneva Q1 2026 Earnings Conference Call
On Wednesday, Valneva (NASDAQ:VALN) discussed first-quarter financial results d...
05-13 23:51
BRIEF-Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology
BRIEF-Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology May 12 (Reuters) - ROCHE HOLDING AG ROPC.S : RECEIVES CE MARK FOR NEW BLOOD TEST TO DETECT ALZHEIMER'S PATHOLOGY Further company coverage: ROPC.S (Gdansk Newsroom) (( gdansk.newsroom@thomsonreuters.com ; +48 587785269;;)
05-12 13:00
374Water Announces Results Of The U.S. Government's PFAS Destruction Test Results, Third-Party Conclusions Presented By Arcadis Confirm Greater Than 99.9% Destruction And Removal Efficiency For Concentrated PFAS Wastes
AirSCWO Destroys PFAS - PermanentlyUnlike conventional treatment approaches that filter or concentrate PFAS, AirSCWO permanently destroys organic contaminants. Results were evaluated by a third party and presented by
04-30 20:42
BRIEF-OpenAI Says When We Detect Someone Attempting To Use Our Tools To Potentially Plan Or Carry Out Violence, We Take Action, Including Revoking Access
BRIEF-OpenAI Says When We Detect Someone Attempting To Use Our Tools To Potentially Plan Or Carry Out Violence, We Take Action, Including Revoking Access April 28 (Reuters) - OPENAI: WHEN WE DETECT SOMEONE ATTEMPTING TO USE OUR TOOLS TO POTENTIALLY PLAN OR CARRY OUT VIOLENCE, WE TAKE ACTION, INCLUDI
04-29 08:56
Abbott Highlights Multi-Biomarker Cancerguard Test Advancing Early Cancer Detection As DETECT-A Study Earns AACR Recognition
Data show how a multi-biomarker class approach improves early-stage cancer detectionAACR will also recognize landmark DETECT-A study publication reporting long-term outcomes supporting the clinical impact of MCEDABBOTT
04-18 03:41
BRIEF-Securetech Innovations Appoints Brian Zucker, Cpa, To Board Of Directors And Audit Committee
BRIEF-Securetech Innovations Appoints Brian Zucker, Cpa, To Board Of Directors And Audit Committee March 31 (Reuters) - Securetech Innovations Inc SCTH.PK : SECURETECH INNOVATIONS APPOINTS BRIAN ZUCKER, CPA, TO BOARD OF DIRECTORS AND AUDIT COMMITTEE Source text: ID:nGNX2sLjBK Further company coverag
03-31 20:43
